Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
May 09, 2024 08:30 ET
|
Quoin Pharmaceuticals, Inc.
FDA clearance to recruit teens in both on-going Netherton Syndrome clinical studies U.S. and International patent filed for novel Netherton Syndrome combination product Cash runway extended into...
Acorn’s Q1’24 EPS Improves to $0.03 vs. ($0.03) Loss Per Share on Continued Growth in Remote Monitoring and Control Hardware and Services Revenue
May 09, 2024 07:58 ET
|
Acorn Energy, Inc.
Acorn’s Q1’24 EPS Improves to $0.03 vs. ($0.03) Loss on Continued Growth in Remote Monitoring & Control Hardware & Services Revenue 11am call 844-834-0644
Kelly Reports First-Quarter 2024 Earnings
May 09, 2024 07:30 ET
|
Kelly Services, Inc.
Q1 operating earnings of $26.8 million, or up 34% on an adjusted basis Q1 revenue down following sale of European staffing operations; down 2.6% on an organic basis Q1 adjusted EBITDA margin increased...
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
May 09, 2024 07:04 ET
|
Standard Lithium
STRATEGIC EXECUTION SECURES LEADING GLOBAL ENERGY PARTNER, EQUINOR. INJECTS IMMEDIATE LIQUIDITY THROUGH DIRECT INVESTMENTS IN SOUTH WEST ARKANSAS AND EAST TEXAS PROJECTS PARTNERSHIP BRINGS...
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligns with U.S. Food and...
LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook
May 09, 2024 07:00 ET
|
LanzaTech Inc.
LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024 07:00 ET
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics today reported business highlights and financial results for the first quarter ending March 31, 2024.
Aveanna Healthcare Holdings Announces First Quarter 2024 Financial Results and Revised 2024 Outlook
May 09, 2024 06:30 ET
|
Aveanna Healthcare Holdings, Inc
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to...
Kneat Announces Record Revenue for First Quarter 2024
May 08, 2024 17:33 ET
|
kneat.com, inc.
Kneat maintains 35% year-over-year revenue growth to surpass $10 million quarterly revenue mark, as annual recurring revenue growth accelerates to 57%.
Savaria starts fiscal 2024 with elevated margins
May 08, 2024 17:05 ET
|
Savaria Corporation
LAVAL, Québec, May 08, 2024 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for the...